Products for Research Use Only
RegisterLogin

Lumiliximab

CAT: 0804-HY-P99303-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99303-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1].
CAS Number
357613-86-6
Product Name Alternative
Gomiliximab; IDEC-152; ST-152
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/lumiliximab.html
Purity
99.82
Solubility
H2O
Smiles
[Lumiliximab]
Molecular Weight
(144.82 kDa)
References & Citations
[1]Poole JA, et al. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol. 2005 Oct;116 (4) :780-8.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T77456-01Lumiliximab
591984Lumiliximab (FCER2)
GTR18333592-01Lumiliximab Antibody
DHC21301Research Grade Lumiliximab
E55B0323Lumiliximab (Reference antibody)
GTR18780677-01(Lumiliximab) Biosimilar Reference Antibody
C00300-1mgLumiliximab (Anti-FceR2 / CD23)
ICH5658-25mgLumiliximab Biosimilar - Research Grade
GTR18697919-01Lumiliximab Chimeric Monoclonal Antibody
047970FceR2/CD23 (lumiliximab) discontinued

Popular Products